Renal transplantation in elderly patients older than 70 years of age: Results from the scientific registry of transplant recipients

被引:337
作者
Rao, Panduranga S.
Merion, Robert M.
Ashby, Valarie B.
Port, Friedrich K.
Wolfe, Robert A.
Kayler, Liise K.
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Sci Registry Transplant Recipients, Ann Arbor, MI USA
[3] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[5] Arbor Res Collaborat Hlth, Ann Arbor, MI USA
[6] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA
关键词
renal transplantation; elderly patients;
D O I
10.1097/01.tp.0000259621.56861.31
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Elderly patients (ages 70 yr and older) are among the fastest-growing group starting renal-replacement therapy in the United States. The outcomes of elderly patients who receive a kidney transplant have not been well studied compared with those of their peers on the waiting list. Methods. Using the Scientific Registry of Transplant Recipients, we analyzed data from 5667 elderly renal transplant candidates who initially were wait-listed from January 1, 1990 to December 31, 2004. Of these candidates, 2078 received a deceased donor transplant, and 360 received a living donor transplant by 31 December 2005. Time-to-death was studied using Cox regression models with transplant as a time-dependent covariate. Mortality hazard ratios (RRs) of transplant versus waiting list were adjusted for recipient age, sex, race, ethnicity, blood type, panel reactive antibody, year of placement on the waiting list, dialysis modality, comorbidities, donation service area, and time from first dialysis to first placement on the waiting list. Results. Elderly transplant recipients had a 41% lower overall risk of death compared with wait-listed candidates (RR=0.59; P < 0.0001). Recipients of nonstandard, that is, expanded criteria donor, kidneys also had a significantly lower mortality risk (RR=0.75; P < 0.0001). Elderly patients with diabetes and those with hypertension as a cause of end-stage renal disease also experienced a large benefit. Conclusions. Transplantation offers a significant reduction in mortality compared with dialysis in the wait-listed elderly population with end-stage renal disease.
引用
收藏
页码:1069 / 1074
页数:6
相关论文
共 30 条
[1]  
ALBRECHTSEN D, 1995, TRANSPLANT P, V27, P986
[2]  
[Anonymous], USRDS 2004 ANN DAT R
[3]   RENAL-TRANSPLANTATION FOR PATIENTS 60 YEARS OF AGE OR OLDER - A SINGLE-INSTITUTION EXPERIENCE [J].
BENEDETTI, E ;
MATAS, AJ ;
HAKIM, N ;
FASOLA, C ;
GILLINGHAM, K ;
MCHUGH, L ;
NAJARIAN, JS .
ANNALS OF SURGERY, 1994, 220 (04) :445-460
[4]   Transplantation versus haemodialysis in elderly patients [J].
Bonal, J ;
Cleries, M ;
Vela, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (02) :261-264
[5]   Differences in quality of life across renal replacement therapies: A meta-analytic comparison [J].
Cameron, JI ;
Whiteside, C ;
Katz, J ;
Devins, GM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :629-637
[6]  
DELMONICO FL, 1975, ARCH SURG-CHICAGO, V110, P1107
[7]   Predicting clinical outcome in the elderly renal transplant recipient [J].
Doyle, SE ;
Matas, AJ ;
Gillingham, K ;
Rosenberg, ME .
KIDNEY INTERNATIONAL, 2000, 57 (05) :2144-2150
[8]  
Fabrizii V, 2001, Curr Opin Urol, V11, P159, DOI 10.1097/00042307-200103000-00006
[9]   RENAL REPLACEMENT THERAPY IN ELDERLY PATIENTS [J].
FAUCHALD, P ;
ALBRECHTSEN, D ;
LEIVESTAD, T ;
BERG, KJ ;
TALSETH, T ;
FLATMARK, A .
TRANSPLANT INTERNATIONAL, 1988, 1 (03) :131-134
[10]  
FEHRMAN I, 1989, TRANSPLANT P, V21, P2018